Correlation Between Pasithea Therapeutics and Milestone Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Milestone Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Milestone Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Milestone Pharmaceuticals, you can compare the effects of market volatilities on Pasithea Therapeutics and Milestone Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Milestone Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Milestone Pharmaceuticals.
Diversification Opportunities for Pasithea Therapeutics and Milestone Pharmaceuticals
-0.55 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Pasithea and Milestone is -0.55. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Milestone Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Milestone Pharmaceuticals and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Milestone Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Milestone Pharmaceuticals has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Milestone Pharmaceuticals go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and Milestone Pharmaceuticals
Given the investment horizon of 90 days Pasithea Therapeutics Corp is expected to under-perform the Milestone Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Pasithea Therapeutics Corp is 1.24 times less risky than Milestone Pharmaceuticals. The stock trades about -0.24 of its potential returns per unit of risk. The Milestone Pharmaceuticals is currently generating about 0.29 of returns per unit of risk over similar time horizon. If you would invest 145.00 in Milestone Pharmaceuticals on August 28, 2024 and sell it today you would earn a total of 40.00 from holding Milestone Pharmaceuticals or generate 27.59% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pasithea Therapeutics Corp vs. Milestone Pharmaceuticals
Performance |
| Timeline |
| Pasithea Therapeutics |
| Milestone Pharmaceuticals |
Pasithea Therapeutics and Milestone Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pasithea Therapeutics and Milestone Pharmaceuticals
The main advantage of trading using opposite Pasithea Therapeutics and Milestone Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Milestone Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Milestone Pharmaceuticals will offset losses from the drop in Milestone Pharmaceuticals' long position.| Pasithea Therapeutics vs. Nutriband Warrant | Pasithea Therapeutics vs. MediciNova | Pasithea Therapeutics vs. Eliem Therapeutics | Pasithea Therapeutics vs. Virax Biolabs Group |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |